About Mission Bio
Mission Bio is a Healthcare company based in San Francisco (United States) founded in 2014 by Adam Sciambi and Charlie Silver. Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. Mission Bio has raised $110 million across 13 funding rounds from investors including LabCorp, Agilent and HHS. Its chief executive, as recorded, is Brian Kim. Its website missionbio.com draws about 18 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is MISSION BIO, INC. Its competitors include 10X Genomics, Cellares and LevitasBio; 3 of its 3 listed competitors have raised funding.
Company details
Mission Bio was founded in 2014 in San Francisco, United States, within the biotechnology sector. A single-cell multi-omics platform is developed for genotypic and phenotypic analysis, focusing on cancer applications. The Tapestri platform is employed to detect single nucleotide variants, copy number variations, and proteins concurrently. DNA and protein panels are supplied, alongside Pharma Assay Development services for pharmaceutical needs. Operations are centered in the United States.
- Headquarters San Francisco, United States
- Founders Adam Sciambi, Charlie Silver
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website missionbio.com
- Social LinkedIn X Facebook YouTube
- Legal Name Mission Bio, Inc.
- Total Equity Funding$110M (USD)
in 13 rounds
- InvestorsLabCorp
& 15 more
Apps and channels of Mission Bio
its YouTube channel Mission Bio has 587 subscribers and 30 videos.
Videos from Mission Bio
The most watched videos on Mission Bio's YouTube channel, Mission Bio (587 subscribers). Click a video to play it here.
More on Mission Bio.
Funding Insights of Mission Bio
Mission Bio has successfully raised a total of $110M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $110M
- Total Rounds 13
- First Round $1.54M
(Aug 2014)
- Investors Count 16
Latest 10 of 13 funding rounds of Mission Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | Series C | – | Ally Bridge Group | – | |
| Aug 2020 | $70M | Series C | – | Novo Holdings | |
| Oct 2019 | $2M | Grant | – | – | |
| Sep 2019 | $1.79M | Grant | – | – | |
| Jul 2018 | $30M | Series B | – | Agilent, Cota Capital | – |
| Dec 2017 | $1M | Grant | – | – | |
| Oct 2017 | $10M | Series A | – | Tapestri, Foothill Ventures | |
| Sep 2017 | $951,385 | Grant | – | – | |
| Feb 2017 | Seed | – | Life Science Angels | – | |
| Jun 2016 | $199,665 | Grant | – | – |
16 investors in total: 16 institutional.
Investors in Mission Bio
Mission Bio has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Agilent and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
| soleuscapital.com | ||||
Mayfield is focused on AI innovation and venture capital investments. | mayfield.com | Menlo Park, United States | ||
Stage-agnostic venture capital investments are focused on US sectors. | cotacapital.com | San Francisco, United States | ||
Investments are made in innovative technology companies by Lam Capital. | lamcapital.com | |||
Venture capital fund focused on pre-seed tech startups | foothill.ventures | Los Altos, United States | ||
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Diversified instruments are developed for scientific and laboratory management. | 1995 | agilent.com | Santa Clara, United States | |
Cancer research is conducted and supported by the institute. | cancer.gov | Bethesda, United States |
Investor details for Mission Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mission Bio
42 people are tracked at Mission Bio (18 in leadership, 4 in board & advisors, 20 in team).
| Name | Role | Group |
|---|---|---|
Adam Sciambi | Co-Founder & Chief Technology Officer | Leadership |
Charlie Silver | Co-Founder | Leadership |
Brian Kim | CEO | Leadership |
Brock Siegel | Director | Leadership |
Zara Wang, Ph.D. | Associate Director, Pharma Program Management | Leadership |
Maria Soong | Head Of Inside Sales/business Development | Leadership |
Andrew Reitinger | Associate Director, Business Development | Leadership |
Luke Hayes | CFO | Leadership |
Vanee Pho | Senior Director Product Management- Cell And Gene Therapy | Leadership |
Ramin Chaybani | Head Of International Sales And Support | Leadership |
Joey Perez | Director Of Operations | Leadership |
Daniel Mendoza | Sr. Director Of Product Development | Leadership |
Kayo Yamamura | Vice President Finance | Leadership |
Robert Durruthy-Durruthy | Sr. Director, Technical & Field Applications Support | Leadership |
Zivjena Vucetic | Chief Medical Officer | Leadership |
Stanley Chu | Director Of Logistics | Leadership |
Shu Wang | Executive Director, Bioinformatics | Leadership |
Matthew Cato | Chief Commercial Officer (cco) | Leadership |
Ross L. Levine | Scientific Advisor | Board & advisors |
Jerald Radich | Scientific Advisor | Board & advisors |
22 more people are available in the full profile.
Complete people profiles for Mission Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mission Bio
3 dated milestones of Mission Bio across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Mission Bio is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series C,.
Competitors of Mission Bio
Mission Bio has 3 listed competitors in our database, 3 of them funded. They include 10X Genomics, Cellares and LevitasBio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| cellares.com | 2019 | San Francisco, United States | $355M | Medical devices for cell-based therapy manufacturing are produced. | ||
| levitasbio.com | 2017 | San Francisco, United States | $73.77M | Single-cell imaging platform developed via magnetic levitation technology. |
Detailed competitors of Mission Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mission Bio
The website of Mission Bio (missionbio.com) receives about 17.7K visits a month.
- Monthly visits17.7K
▲ 39.6% vs previous month
Websites whose visitors overlap most with Mission Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| criver.com | 100% | 224.6K | #186,811 | View details | |
| bioke.com | 80% | 15.2K | #1,729,834 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Mission Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mission Bio
Complete news archive for Mission Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mission Bio
Mission Bio was founded in 2014.
Mission Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Brian Kim is the CEO of Mission Bio, as recorded in our data.
Mission Bio is a funded company, having raised a total of $110M across 13 funding rounds to date. The company's 1st funding round was a Grant of $199.67K, raised on Aug 2014.
Mission Bio was founded in 2014 in San Francisco, United States, within the biotechnology sector. A single-cell multi-omics platform is developed for genotypic and phenotypic analysis, focusing on cancer applications. The Tapestri platform is employed to detect single nucleotide variants, copy number variations, and proteins concurrently. DNA and protein panels are supplied, alongside Pharma Assay Development services for pharmaceutical needs. Operations are centered in the United States.
Mission Bio's top competitors include 10X Genomics, Cellares and LevitasBio.
Mission Bio has 16 investors. Key investors include LabCorp, Agilent, HHS, National Cancer Institute, and NHGRI.
Mission Bio operates through Mission Bio, Inc..